University of Michigan rheumatologist Daniel Clauw, M.D., on the potential benefits and risks of using cannabinoids to treat chronic pain. (©JanMika/Shutterstock.com)
Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Psoriatic arthritis is the second approved indication for Taltz in the United States.
FDA Safety Alert for Product Marketed for OA
Limbrel capsules linked to potentially life-threatening health problems.
New Therapeutic Tool for Juvenile Idiopathic Arthritis
The aim of this study: to determine which patients need biologic therapy after starting methotrexate.
Environmental Factors Tied to Lupus
Among the culprits: sunlight, cigarettes, and oral contraceptives.
Interleukin-6: Neurologic Impact in Rheumatoid Arthritis
This inflammatory cytokine may be linked to many of the secondary neuroendocrine and psychological symptoms of RA.
Sex Differences in Lupus Mortality
What underlies the disparity in life expectancy between men and women with SLE?
Treatment Target Shows Promise in Systemic Lupus Erythematosus
The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.
Arthritis Numbers Just the Tip of the Iceberg
Previous figures underestimated the burden of arthritis, especially among younger adults.
Nothing Fishy About Omega Fatty Acids in Lupus
In patients with SLE, increased intake of omega-3 fatty acids led to better sleep and fewer symptoms of depression.
Obesity Is a Weighty Matter in Lupus
Obese patients report higher disease activity, more depressive symptoms, and greater pain and fatigue.